Investigation of the abnormal low-density lipoproteins occurring in patients with obstructive jaundice
- PMID: 183749
- PMCID: PMC1163866
- DOI: 10.1042/bj1570401
Investigation of the abnormal low-density lipoproteins occurring in patients with obstructive jaundice
Abstract
The abnormal lipoproteins of the density range 1.019-1.063g/cm3 occurring in the plasma of patients with obstructive jaundice were studied. Subfractionation of this density class by combined sodium phosphotungstate precipitation, ultracentrifugation, and column chromatography on hydroxyapatite and agarose gel yielded essentially three fractions: (1) lipoprotein-X, (2) A triglyceride-rich lipoprotein for which we propose the term lipoprotein-Y and (3) an abnormal lipoprotein, lipoprotein-B. Marked differences between these fractions with respect to electron-microscopic appearance, hydrated densities, chemical composition and immunochemical characteristics were observed. The protein moiety of lipoprotein-X consisted primarily of apolipoprotein-C and albumin. Lipoprotein-Y showed, in addition to apolipoprotein-C, the presence of apolipoprotein-B. The 'lipoprotein-B' fraction isolated from sera of these patients had higher triglyceride and free cholesterol contents than that of normal individuals and an unusually high content of apolipoprotein-C. The relative distribution of lipoprotein-X, lipoprotein-Y and 'lipoprotein-B' varied from patient to patient. The importance of considering the existence of lipoprotein-Y in screening patients for cholestasis by the lipoprotein-X test is discussed.
Similar articles
-
A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects.J Clin Invest. 1969 Jul;48(7):1211-23. doi: 10.1172/JCI106085. J Clin Invest. 1969. PMID: 4978447 Free PMC article.
-
A lipoprotein characterizing obstructive jaundice. II. Isolation and partial characterization of the protein moieties of low density lipoproteins.J Clin Invest. 1970 Dec;49(12):2396-407. doi: 10.1172/JCI106459. J Clin Invest. 1970. PMID: 5480863 Free PMC article.
-
Lipoprotein abnormalities in cholestasis. I. Electrophoretic and ultracentrifugal analyses.Acta Med Okayama. 1979 Aug;33(4):269-85. Acta Med Okayama. 1979. PMID: 227230
-
Characterization of plasma lipoproteins separated and purified by agarose-column chromatography.Biochem J. 1974 Apr;139(1):89-95. doi: 10.1042/bj1390089. Biochem J. 1974. PMID: 4377101 Free PMC article.
-
Lipoprotein-X.CRC Crit Rev Clin Lab Sci. 1979 Aug;11(1):31-51. doi: 10.3109/10408367909105853. CRC Crit Rev Clin Lab Sci. 1979. PMID: 389551 Review.
Cited by
-
[The apolipoproteins in man ].Klin Wochenschr. 1982 Jul 1;60(13):673-49. doi: 10.1007/BF01716796. Klin Wochenschr. 1982. PMID: 6750220 Review. German.
-
The role of lecithin: cholesterol acyltransferase for lipoprotein (a) assembly. Structural integrity of low density lipoproteins is a prerequisite for Lp(a) formation in human plasma.J Clin Invest. 1994 Dec;94(6):2330-40. doi: 10.1172/JCI117598. J Clin Invest. 1994. PMID: 7989589 Free PMC article.
-
Secretion of lipoprotein-X by perfused livers of rats with cholestasis.Proc Natl Acad Sci U S A. 1978 Jul;75(7):3459-63. doi: 10.1073/pnas.75.7.3459. Proc Natl Acad Sci U S A. 1978. PMID: 277947 Free PMC article.
-
LCAT Enzyme Replacement Therapy Reduces LpX and Improves Kidney Function in a Mouse Model of Familial LCAT Deficiency.J Pharmacol Exp Ther. 2019 Mar;368(3):423-434. doi: 10.1124/jpet.118.251876. Epub 2018 Dec 18. J Pharmacol Exp Ther. 2019. PMID: 30563940 Free PMC article.
-
Features of Lipid Metabolism Disorders in Primary Biliary Cholangitis.Biomedicines. 2022 Nov 25;10(12):3046. doi: 10.3390/biomedicines10123046. Biomedicines. 2022. PMID: 36551803 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources